Literature DB >> 10493801

A switch in the kinase domain of rat testis 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase.

M H Yuen1, X L Wang, H Mizuguchi, K Uyeda, C A Hasemann.   

Abstract

The bifunctional enzyme 6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase plays an essential role in the regulation of glucose metabolism by both producing and degrading Fru-2,6-P(2) via its distinct catalytic activities. The 6-PF-2-K and Fru-2,6-P(2)ase active sites are located in separate domains of the enzyme. The kinase domain is structurally related to the superfamily of mononucleotide binding proteins that includes adenylate kinase and the G-proteins. We have determined three new structures of the enzymatic monomer, each with a different ligand in the ATP binding site of the 6-PF-2-K domain (AMP-PNP, PO(4), and water). A comparison of these three new structures with the ATPgammaS-bound 6-PF-2-K domain reveals a rearrangement of a helix that is dependent on the ligand bound in the ATP binding site of the enzyme. This helix motion dramatically alters the position of a catalytic residue (Lys172). This catalytic cation is analogous to the Arg residue donated by the rasGAP protein, and the Arg residue at the core of the GTP or GDP sensing switch motion seen in the heterotrimeric G-proteins. In addition, a succinate molecule is observed in the Fru-6-P binding site. Kinetic analysis of succinate inhibition of the 6-PF-2-K reaction is consistent with the structural findings, and suggests a mechanism for feedback inhibition of glycolysis by citric acid cycle intermediates. Alterations in the 6-PF-2-K kinetics of several proteins mutated near both the switch and the succinate binding site suggest a mode of communication between the ATP- and F6P binding sites. Together with these kinetic data, these new structures provide insights into the mechanism of the 6-PF-2-K activity of this important bifunctional enzyme.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10493801     DOI: 10.1021/bi991268+

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  5 in total

1.  Intramolecular regulation of the opposing (p)ppGpp catalytic activities of Rel(Seq), the Rel/Spo enzyme from Streptococcus equisimilis.

Authors:  Undine Mechold; Helen Murphy; Larissa Brown; Michael Cashel
Journal:  J Bacteriol       Date:  2002-06       Impact factor: 3.490

2.  Crystal structure of heart 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (PFKFB2) and the inhibitory influence of citrate on substrate binding.

Authors:  Robert B Crochet; Jeong-Do Kim; Herie Lee; Young-Sun Yim; Song-Gun Kim; David Neau; Yong-Hwan Lee
Journal:  Proteins       Date:  2016-11-29

Review 3.  Minor structural changes, major functional impacts: posttranslational modifications and drug targets.

Authors:  Hyo Jung Kim
Journal:  Arch Pharm Res       Date:  2022-10-17       Impact factor: 6.010

4.  CD44ICD promotes breast cancer stemness via PFKFB4-mediated glucose metabolism.

Authors:  Ruifang Gao; Dan Li; Jing Xun; Wei Zhou; Jun Li; Juan Wang; Chen Liu; Xiru Li; Wenzhi Shen; Huan Qiao; Dwayne G Stupack; Na Luo
Journal:  Theranostics       Date:  2018-11-29       Impact factor: 11.556

5.  PFKFB4 promotes angiogenesis via IL-6/STAT5A/P-STAT5 signaling in breast cancer.

Authors:  Dan Li; Jiaping Tang; Ruifang Gao; Jinxin Lan; Wenzhi Shen; Yanhua Liu; Yanan Chen; Hongwei Sun; Jie Yan; Yongwei Nie; Na Luo
Journal:  J Cancer       Date:  2022-01-01       Impact factor: 4.207

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.